HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM.

Some insulin-dependent diabetic (IDDM) patients develop severe forms of retinopathy. Putative risk factors such as hypertension, poor metabolic control, nephropathy and growth hormone levels do not fully explain the progress of retinopathy in these patients. It has been discussed whether there is a genetic marker, since some diabetic patients without any known predisposing risk factors develop severe retinopathy and others do not. In the present study, HLA-DR and DQ were compared in two patient groups with IDDM. One group consisted of patients with early-onset diabetes, with severe non-proliferative or proliferative retinopathy; the other group had no or only mild signs of retinopathy. High resolution HLA typing was carried out by polymerase chain reaction (PCR) and hybridization with allele specific probes. Alleles on the DR3-DQ2 haplotype, DRB10301, DQA10501 and DQB10201, were more frequent in patients with severe retinopathy. A difference was seen when combining certain alleles in the genotypes of DQA103/0501 (p > 0.05) and DQB10201/0302 (p < 0.01). The findings of the present study suggest that DQB10201/0302 is the strongest genetic marker for severe retinopathy and DRB10301/0401 only has a secondary influence when combined with this genotype. It seems as if IDDM patients who are positive for the genotype DR3-DQ2/DR4-DQ8 (DRB10301-DQA10501-DQB10201/DRB10401 -DQA103-DQB1*0302) are at greater risk of developing severe retinopathy.